These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9459320

  • 1. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
    Forastiero R, Martinuzzo M, Carreras LO, Maclouf J.
    Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320
    [Abstract] [Full Text] [Related]

  • 2. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL, Leung S, Miller-Blair DJ, Ziboh V.
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [Abstract] [Full Text] [Related]

  • 3. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO.
    Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G, Ferro D, Basili S, Iuliano L, Camastra C, Giammarresi C, Santarone S, Rocca B, Landolfi R, Ciabattoni G, Cordova C, Violi F.
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 12. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
    Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO.
    J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762
    [Abstract] [Full Text] [Related]

  • 13. Real world experience with antiphospholipid antibody tests: how stable are results over time?
    Erkan D, Derksen WJ, Kaplan V, Sammaritano L, Pierangeli SS, Roubey R, Lockshin MD.
    Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
    [Abstract] [Full Text] [Related]

  • 14. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS.
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N.
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [Abstract] [Full Text] [Related]

  • 16. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 17. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA, van Oort E, Tempelman MJ, Derksen RH, de Groot PG.
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [Abstract] [Full Text] [Related]

  • 18. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 19. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J.
    Verh K Acad Geneeskd Belg; 2000 Nov; 62(5):353-72. PubMed ID: 11144685
    [Abstract] [Full Text] [Related]

  • 20. Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies.
    Galli M, Daldossi M, Barbui T.
    Thromb Haemost; 1994 May; 71(5):571-5. PubMed ID: 8091382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.